BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27494133)

  • 21. Guinea pig serum erythropoietin (EPO) selectively stimulates guinea pig erythroid progenitors: human or mouse erythroid progenitors do not form erythroid burst-forming unit colonies in response to guinea pig serum EPO.
    Stopka T; Zivny JH; Goldwasser E; Prchal JF; Necas E; Prchal JT
    Exp Hematol; 1998 Aug; 26(9):910-4. PubMed ID: 9694513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring erythropoiesis of common carp (Cyprinus carpio) using an in vitro colony assay in the presence of recombinant carp kit ligand A and erythropoietin.
    Katakura F; Yabu T; Yamaguchi T; Miyamae J; Shirinashihama Y; Nakanishi T; Moritomo T
    Dev Comp Immunol; 2015 Nov; 53(1):13-22. PubMed ID: 26111997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
    Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
    J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
    Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
    Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2/STAT5 signaling pathway.
    Chen D; Zuo G; Li C; Hu X; Guan T; Jiang R; Li J; Lin X; Li F; Luo C; Wang H; Lei C; Long X; Wang Y; Wang J
    J Ethnopharmacol; 2009 Nov; 126(2):215-20. PubMed ID: 19735711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
    Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
    Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
    Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP
    Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
    Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
    Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
    Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ΗΙF1α, EGR1 and SP1 co-regulate the erythropoietin receptor expression under hypoxia: an essential role in the growth of non-small cell lung cancer cells.
    Su T; Liu P; Ti X; Wu S; Xue X; Wang Z; Dioum E; Zhang Q
    Cell Commun Signal; 2019 Nov; 17(1):152. PubMed ID: 31752873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.
    Dagnon K; Pacary E; Commo F; Antoine M; Bernaudin M; Bernaudin JF; Callard P
    Clin Cancer Res; 2005 Feb; 11(3):993-9. PubMed ID: 15709164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density].
    Han ZG; Yu TT; Shan L
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):605-8. PubMed ID: 23158995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
    Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
    J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion.
    Doleschel D; Rix A; Arns S; Palmowski K; Gremse F; Merkle R; Salopiata F; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    Theranostics; 2015; 5(8):905-18. PubMed ID: 26000061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
    Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.